I’ve noted discussion and some with concern about the possibility of the FDA raising concerns about the potential of a side effect diarrhoea unblinding the trial.
If that we’re to be an issue, then how could you possibly re visit a drug that has a side effect compared to the placebo. You would never be able to test the drug.
you can’t give another medication as it would unblind it before starting.
I can only assume you need to interpret the data as it is.
Q. How can you keep a trial blinded that has a known side effect?
The best time is before it’s a known side effect and that’s
with the first trial which we’ve already done.
Share Price, page-2094
-
- There are more pages in this discussion • 10,054 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |